Practice
Open Access
Lymphogranuloma venereum
Eric J. Eckbo, Malcolm Hedgcock and Troy Grennan
CMAJ December 13, 2021 193 (49) E1889; DOI: https://doi.org/10.1503/cmaj.210853
Eric J. Eckbo
Vancouver Coastal Health, Division of Medical Microbiology & Infection Control (Eckbo), University of British Columbia, Faculty of Medicine, Department of Pathology & Laboratory Medicine (Eckbo); Spectrum Health (Hedgcock); British Columbia Centre for Disease Control, STI/HIV Services (Grennan); University of British Columbia, Faculty of Medicine, Division of Infectious Diseases (Grennan), Vancouver, BC
MDMalcolm Hedgcock
Vancouver Coastal Health, Division of Medical Microbiology & Infection Control (Eckbo), University of British Columbia, Faculty of Medicine, Department of Pathology & Laboratory Medicine (Eckbo); Spectrum Health (Hedgcock); British Columbia Centre for Disease Control, STI/HIV Services (Grennan); University of British Columbia, Faculty of Medicine, Division of Infectious Diseases (Grennan), Vancouver, BC
MDTroy Grennan
Vancouver Coastal Health, Division of Medical Microbiology & Infection Control (Eckbo), University of British Columbia, Faculty of Medicine, Department of Pathology & Laboratory Medicine (Eckbo); Spectrum Health (Hedgcock); British Columbia Centre for Disease Control, STI/HIV Services (Grennan); University of British Columbia, Faculty of Medicine, Division of Infectious Diseases (Grennan), Vancouver, BC
MD MScIn this issue
Article tools
Lymphogranuloma venereum
Eric J. Eckbo, Malcolm Hedgcock, Troy Grennan
CMAJ Dec 2021, 193 (49) E1889; DOI: 10.1503/cmaj.210853
Jump to section
- Article
- Lympogranuloma venereum (LGV) is an aggressive, sexually transmitted infection caused by specific strains of Chlamydia trachomatis
- Lympogranuloma venereum can have variable presentations that can be misdiagnosed
- People with symptoms suggestive of LGV, or risk factors, should be tested for C. trachomatis using a nucleic acid amplification test (NAAT)
- Treatment for LGV is longer than for other forms of chlamydia
- Sexual partners should be treated empirically with the same regimen as a diagnosed case, pending test results
- Acknowledgments
- Footnotes
- References
- Responses
- Metrics